Are GSVs a more accurate measurement of change?
Presenters: Lynsey Psimas, PhD and Paul Williams PsyD
Growth Scale Values (GSVs) have a long 50-year history within research. However, GSVs are only now gaining traction as an alternative and more precise way to measure outcomes in clinical trials.
This recorded presentation answers the questions:
- What are GSVs?
- Why are GSVs great for tracking change over time?
- Which tests currently offer GSVs scores?
- How do you compare GSVs to other metrics such as Raw Scores, Age Equivalents, and Norm-Referenced Scores?
- How do you interpret GSVs and scaled score performance?
About the presenters
J. Lynsey Psimas, PhD
Director of Pharma Sales
Dr. Psimas is a licensed Clinical Psychologist with extensive experience in the assessment of children, adolescents, and adults. She has worked in private practice, therapeutic schools, and as a professor. She specializes in neuropsychological assessment, autism, ADHD, and learning disabilities.
Do you have a question? Contact us to start the conversation.
Paul Williams, PsyD
Senior Account Manager
Dr. Williams has extensive experience providing a variety of mental health services including neuropsychological assessment and psychotherapy with a specialization in adolescents. He came to Pearson in 2002 as a Senior Research Director, leading several teams in the development of a variety of assessments including the Bayley™, WISC®, and WAIS®. Dr. Williams now works as a Senior Pharma Account Manager.
Do you have a question? Contact us to start the conversation.
Pharma Research Services
Supporting clinical research with an 80 year history in measurement science
